Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Argent BioPharma Ltd (RGT)

Sydney
Currency in AUD
Disclaimer
0.415
+0.010(+2.47%)
Closed

RGT Price Commentary

OMG at these levels I've had to buy another 10k shares, I now hold 70k here and man does the future look bright for this company. Anyone who hasn't done their DD on this needs to ASAP. Clear road map ahead and the company will be at break-even by the end of H1 21, Orders are being scaled up and the Co still has access to 9.5mill debt facility! This is a long term winner here, holding for gold and buying up these small dips. Not advice but my personal views, check out over at LSE and read the detailed posts from Ehsan and check out the previous RNSs
Just bought after doing DD looks a good company going forward.
Absolutely, this is a great time to get in, I really can't believe it's at this price still. So many positives and this company director is very well connected with many years experience in pharmaceuticals. I'll eat my words if don't see a significant increase, may just have to wait for the financial predictions in March. I'm happy either way as it gives me longer to top up... hoping to top up my holding to 100k shares once some more funds clear, I just hope the price remains where it is for payday on Friday.
loltastic at 2.59p
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.